Vera Therapeutics (VERA) Current Leases (2022 - 2025)

Vera Therapeutics has reported Current Leases for 4 years, with the latest figure at $549000.0 in Q4 2025.

• For the quarter ending Q4 2025, Current Leases fell 62.98% year-over-year to $549000.0; the trailing twelve-month figure through Dec 2025 stood at $549000.0 (down 62.98% YoY), and the FY2025 full-year result was $549000.0, down 62.98% from the prior year.
• Current Leases for Q4 2025 stood at $549000.0, up from $473000.0 in the prior quarter.
• The five-year high for Current Leases was $2.7 million in Q3 2022, with the low at $473000.0 in Q3 2025.
• Historically, Current Leases has averaged $2.0 million across 4 years, with a median of $2.4 million in 2023.
• Annual changes were most pronounced in 2023 — Current Leases climbed 4.5% — and 2025, when it plunged 74.73%.
• Vera Therapeutics' Current Leases stood at $2.6 million in 2022, then retreated by 7.9% to $2.4 million in 2023, then slumped by 39.12% to $1.5 million in 2024, then slumped by 62.98% to $549000.0 in 2025.
• The last three Current Leases figures came in at $549000.0 (Q4 2025), $473000.0 (Q3 2025), and $855000.0 (Q2 2025), per Business Quant data.